Biotech Reelected for 4 consecutive years! Medicilon is on the list of “Top 20 Chinese R&D CRO Enterprises in 2023” Bymedicilon July 12, 2023
Biotech Biopharmaceuticals – Preclinical safety evaluation of prophylactic biological products Bymedicilon June 29, 2023
Biotech Reelected for 4 consecutive years! Medicilon is on the list of “Top 20 Chinese R&D CRO Enterprises in 2023” Bymedicilon June 26, 2023
Biotech Medicilon congratulates MindRank’s GLP-1RA small molecule oral drug for successfully administering the first subject in clinical phase I Bymedicilon June 26, 2023
Biotech Medicilon Assists Toll Biotech’s TollB-001 tablets, a new class 1.1 drug, to officially approve for clinical trials by the FDA Bymedicilon June 21, 2023
Biotech To build an integrated AI platform for early drug discovery and evaluation, Medicilon and DP Technology reached a strategic collaboration Bymedicilon June 21, 2023
Biotech Medicilon interview with Dr. Fei Zhang | Walking in the dark with a light, Raymon Pharma’s new medicinal technology benefits eye health Bymedicilon June 15, 2023